trial · primary record
nab-sirolimus
Tumor, Solid
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 15 |
| Primary completion | 2026-09-02 |
| Primary endpoint | MTD for patients with moderate hepatic impairment |
| Registry ID | NCT05661461 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:44:07.502Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05661461
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Nab-Sirolimus · compound